Analysis of comorbidity and its association with disease severity and mortality rate in hospitalized COVID-19 patients
Jurnal Respirologi Indonesia
; 42(1):18-25, 2022.
Article
in English
| CAB Abstracts | ID: covidwho-1994967
ABSTRACT
Background:
Comorbidity is a major factor in determining the outcome of COVID-19. However, existing studies regarding comorbidities and the disease severity and mortality of COVID-19 are mostly based on studies in the whole community, and not on those admitted to hospitals. This study aims to determine the demographic profile of comorbidities among COVID-19 patients hospitalized in tertiary care referral hospitals and its association with disease severity and mortality.
Prion, Viral, Bacterial and Fungal Pathogens of Humans [VV210]; Non-communicable Human Diseases and Injuries [VV600]; comorbidity; coronavirus disease 2019; demography; diabetes; diabetes mellitus; disease course; heart; heart diseases; heart failure; hospital admission; hospitals; human diseases; hypertension; lungs; mortality; pandemics; respiratory diseases; viral diseases; man; Severe acute respiratory syndrome coronavirus 2; Indonesia; Java; APEC countries; ASEAN Countries; high Human Development Index countries; lower-middle income countries; South East Asia; Asia; Sunda Islands; Homo; Hominidae; primates; mammals; vertebrates; Chordata; animals; eukaryotes; Severe acute respiratory syndrome-related coronavirus; Betacoronavirus; Coronavirinae; Coronaviridae; Nidovirales; positive-sense ssRNA Viruses; ssRNA Viruses; RNA Viruses; viruses; disease progression; coronary diseases; high blood pressure; Jawa; death rate; lung diseases; SARS-CoV-2; viral infections
Full text:
Available
Collection:
Databases of international organizations
Database:
CAB Abstracts
Type of study:
Prognostic study
Language:
English
Journal:
Jurnal Respirologi Indonesia
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS